Literature DB >> 6642665

Differential complement activation and susceptibility to human serum bactericidal action by Vibrio species.

M L Tamplin, S Specter, G E Rodrick, H Friedman.   

Abstract

The ability of Vibrio vulnificus to resist human serum bactericidal action and to activate human complement was compared with similar cultures of Vibrio cholerae and Vibrio parahaemolyticus. Both V. vulnificus and V. parahaemolyticus had similar survival rates in sera and were much more resistant to killing than was V. cholerae. In contrast, V. vulnificus activated significantly less serum complement than did V. cholerae and V. parahaemolyticus. The relative ability of V. vulnificus to survive in serum and activate less complement than other Vibrio spp. tested may be related to its ability to cause chronic tissue infections and septicemias.

Entities:  

Mesh:

Year:  1983        PMID: 6642665      PMCID: PMC264424          DOI: 10.1128/iai.42.3.1187-1190.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

1.  Spontaneous colon bacillus bacteremia in Laennec's cirrhosis.

Authors:  W A TISDALE
Journal:  Gastroenterology       Date:  1961-01       Impact factor: 22.682

2.  Spontaneous bacterial peritonitis in cirrhosis: variations on a theme.

Authors:  H O Conn; J M Fessel
Journal:  Medicine (Baltimore)       Date:  1971-05       Impact factor: 1.889

Review 3.  A molecular concept of immune cytolysis.

Authors:  H J Muller-Eberhard; U R Nilsson; A P Dalmasso; M J Polley; M A Calcott
Journal:  Arch Pathol       Date:  1966-09

4.  Collagenolytic activity of Vibrio vulnificus: potential contribution to its invasiveness.

Authors:  G C Smith; J R Merkel
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

5.  Disease caused by a marine vibrio--Vibrio vulnificus.

Authors:  E P Ellington; J G Wood; E O Hill
Journal:  N Engl J Med       Date:  1982-12-23       Impact factor: 91.245

6.  Bacteraemia in association with hepatocellular and hepatobiliary disease.

Authors:  E A Jones; S Sherlock; N Crowley
Journal:  Postgrad Med J       Date:  1967-03       Impact factor: 2.401

7.  Isolation and characterization of Vibrio vulnificus from two Florida estuaries.

Authors:  M Tamplin; G E Rodrick; N J Blake; T Cuba
Journal:  Appl Environ Microbiol       Date:  1982-12       Impact factor: 4.792

8.  Serum-induced lysis of Pseudomonas aeruginosa.

Authors:  T Meshulam; H Verbrugh; J Verhoef
Journal:  Eur J Clin Microbiol       Date:  1982-02       Impact factor: 3.267

9.  Role of iron in the pathogenesis of Vibrio vulnificus infections.

Authors:  A C Wright; L M Simpson; J D Oliver
Journal:  Infect Immun       Date:  1981-11       Impact factor: 3.441

10.  Receptors for complement of leukocytes.

Authors:  W H Lay; V Nussenzweig
Journal:  J Exp Med       Date:  1968-11-01       Impact factor: 14.307

View more
  11 in total

Review 1.  Hepcidin: the missing link between hemochromatosis and infections.

Authors:  Houman Ashrafian
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

Review 2.  Vibrio vulnificus: disease and pathogenesis.

Authors:  Melissa K Jones; James D Oliver
Journal:  Infect Immun       Date:  2009-03-02       Impact factor: 3.441

3.  Pathogenesis of infection by clinical and environmental strains of Vibrio vulnificus in iron-dextran-treated mice.

Authors:  A M Starks; T R Schoeb; M L Tamplin; S Parveen; T J Doyle; P E Bomeisl; G M Escudero; P A Gulig
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

4.  Relation of capsular materials and colony opacity to virulence of Vibrio vulnificus.

Authors:  S Yoshida; M Ogawa; Y Mizuguchi
Journal:  Infect Immun       Date:  1985-02       Impact factor: 3.441

5.  Plasmid-associated resistance of Salmonella typhimurium to complement activated by the classical pathway.

Authors:  J L Vandenbosch; D K Rabert; G W Jones
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

Review 6.  Current perspectives on the epidemiology and pathogenesis of clinically significant Vibrio spp.

Authors:  J M Janda; C Powers; R G Bryant; S L Abbott
Journal:  Clin Microbiol Rev       Date:  1988-07       Impact factor: 26.132

7.  Phage therapy of local and systemic disease caused by Vibrio vulnificus in iron-dextran-treated mice.

Authors:  Karen E Cerveny; Angelo DePaola; Donna H Duckworth; Paul A Gulig
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

8.  Emergence of bactericidal and opsonizing antibody to Vibrio vulnificus following bacterial infection.

Authors:  D M Musher; M V Hansen; A Goree; F Gyorkey; A J Chapman; R E Baughn
Journal:  J Clin Microbiol       Date:  1986-03       Impact factor: 5.948

9.  Vibrio vulnificus resists phagocytosis in the absence of serum opsonins.

Authors:  M L Tamplin; S Specter; G E Rodrick; H Friedman
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

10.  Non-O1 Vibrio cholerae NRT36S produces a polysaccharide capsule that determines colony morphology, serum resistance, and virulence in mice.

Authors:  J A Johnson; P Panigrahi; J G Morris
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.